The Robot Report

  • Research
  • Technologies
    • Batteries / Power Supplies
    • Cameras / Imaging / Vision
    • Controllers
    • Grippers / End Effectors
    • Microprocessors / SoCs
    • Motion Control
    • Sensors / Sensing Systems
    • Soft Robotics
    • Software / Simulation
  • Development
    • A.I. / Cognition
    • Human Robot Interaction / Haptics
    • Mobility / Navigation
  • Robots
    • AGVs
    • AMRs
    • Consumer
    • Collaborative Robots
    • Drones
    • Exoskeletons
    • Self-Driving Vehicles
    • Unmanned Maritime Systems
  • Markets
    • Agriculture
    • Defense / Security
    • Healthcare
    • Logistics
    • Manufacturing
    • Mining
  • Investments
  • Resources
    • COVID-19
    • Digital Issues
    • Publications
      • Collaborative Robotics Trends
      • Robotics Business Review
    • RBR50
    • Search Robotics Database
    • Videos
    • Webinars
  • Events
    • RoboBusiness Direct
    • Robotics Summit & Expo
    • Healthcare Robotics Engineering Forum
    • DeviceTalks
    • R&D 100
  • Podcast

Corindus submits CorPath GRX to FDA for robotic neurovascular interventions

By Fink Densford | February 16, 2019

Corindus submits CorPath GRX to FDA for robotic neurovascular interventions

Corindus Vascular Robotics this week said it applied to the U.S. Food and Drug Administration for premarket clearance to use its CorPath GRX robotic surgical platform in neurovascular interventions.

The Waltham, Mass.-based company has already received FDA clearance for percutaneous coronary interventions (PCI), which it won in 2016, and for peripheral vascular interventions (PVI), which it won last year.

“The ability to treat neurovascular disease with CorPath GRX is the first step for physicians to gain critical experience with robotics,” stated Dr. Aquilla Turk, chief medical officer of Corindus Inc. “Applying the benefits of robotic precision to neurovascular intervention, while building a wealth of clinical knowledge and expertise, are key to preparing for a future of remote stroke treatment.”

Corindus claimed that if it receives the clearance, the CorPath GRX system would be the world’s first and only robotic platform indicated for all three indications — PCI, PVI, and neurovascular interventions or NVI.

“An expansion of CorPath GRX to treat neurovascular conditions would represent a major stepping stone towards our goal of revolutionizing stroke treatment,” said Mark Toland, Corindus president and CEO. “We believe that our current robotic platform will bring benefits to neurovascular procedures today.”

“We will leverage our recent achievements in telerobotics and strong focus on technology development to build a remote stroke solution to tackle the challenge of access to care,” he added. “This would extend the reach of highly-skilled specialists across the globe by granting remote access to patients suffering from life-altering diseases where access to care is limited and time to treatment is paramount.”

Last spring, Corindus raised $25 million in Series A funding to help commercialize the CorPath GRX system, and it received FDA approval for the Rotate on Retract proprietary software to control the CorPath GRX’s movement.

Last December, Corindus touted that its CorPath robotic surgical platform was used in a first in-human telerobotic intervention study in India.

Tell Us What You Think! Cancel reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Related Articles Read More >

TransEnterix submits first machine vision system for robotic surgery to the FDA
TransEnterix machine vision system for robotic surgery receives CE Mark
Laser-steering microrobot aims to refine minimally invasive surgery
Orthosensor Mako Surgical robots
Stryker acquires OrthoSensor to enhance Mako surgical robots
Distalmotion Dexter surgical robot receives European CE Mark

Robotics Year in Review

The Robot Report Listing Database

Latest Robotics News

Robot Report Podcast

Teradyne’s acquisition strategy & the future of cobot

The Robot Report Podcast · Teradyne's acquisition strategy & the future of cobots

Sponsored Content

  • Doosan Robotics: Driving Innovation and Growth in Cobots
  • FORT Robotics Podcast: FORT Robotics on how to keep humans safe and in control of robots
  • Pallet Detection Systems Help Automated Forklifts Modernize Warehouse Operations
  • IES Servo Control Gripper
  • How to cut the cost of manufacturing

Tweets by RoboticTips

The Robot Report
  • Collaborative Robotics Trends
  • Field Robotics Forum
  • Healthcare Robotics Engineering Forum
  • RoboBusiness Event
  • Robotics Business Review
  • Robotics Summit & Expo
  • About The Robot Report
  • Subscribe
  • Advertising
  • Contact Us

Copyright © 2021 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media. Site Map | Privacy Policy | RSS

Search The Robot Report

  • Research
  • Technologies
    • Batteries / Power Supplies
    • Cameras / Imaging / Vision
    • Controllers
    • Grippers / End Effectors
    • Microprocessors / SoCs
    • Motion Control
    • Sensors / Sensing Systems
    • Soft Robotics
    • Software / Simulation
  • Development
    • A.I. / Cognition
    • Human Robot Interaction / Haptics
    • Mobility / Navigation
  • Robots
    • AGVs
    • AMRs
    • Consumer
    • Collaborative Robots
    • Drones
    • Exoskeletons
    • Self-Driving Vehicles
    • Unmanned Maritime Systems
  • Markets
    • Agriculture
    • Defense / Security
    • Healthcare
    • Logistics
    • Manufacturing
    • Mining
  • Investments
  • Resources
    • COVID-19
    • Digital Issues
    • Publications
      • Collaborative Robotics Trends
      • Robotics Business Review
    • RBR50
    • Search Robotics Database
    • Videos
    • Webinars
  • Events
    • RoboBusiness Direct
    • Robotics Summit & Expo
    • Healthcare Robotics Engineering Forum
    • DeviceTalks
    • R&D 100
  • Podcast